Effects of Hemopure™ on Maximal Oxygen Uptake and Endurance Performance in Healthy Humans

Abstract

Haemoglobin-based oxygen carriers (HBOCs) such as Hemopure™ are touted as a tenable substitute for red blood cells and therefore potential doping agents, although the mechanisms of oxygen transport of HBOCs are incompletely understood. We investigated whether infusion of Hemopure™ increased maximal oxygen uptake (V·O_2max) and endurance performance in healthy subjects. Twelve male subjects performed two 4-minute submaximal exercise bouts equivalent to 60 % and 75 % of V·O_2max on a cycle ergometer, followed by a ramped incremental protocol to elicit V·O_2max. A crossover design tested the effect of infusing either 30 g (6 subjects) or 45 g (6 subjects) of Hemopure™ versus a placebo. Under our study conditions, Hemopure™ did not increase V·O_2max nor endurance performance. However, the infusion of Hemopure™ caused a decrease in heart rate of ∼ 10 bpm (p = 0.009) and an average increase in mean (∼ 7 mmHg) and diastolic blood pressure (∼ 8 mmHg) (p = 0.046) at submaximal and maximal exercise intensities. Infusion of Hemopure™ did not bestow the same physiological advantages generally associated with infusion of red blood cells. It is conceivable that under exercise conditions, the hypertensive effects of Hemopure™ counter the performance-enhancing effect of improved blood oxygen carrying capacity.

Key words

Blood doping - exercise - V·O_2max - HBOC - athletes

References

• 1 Brien A J, Simon T L. The effects of red blood cell infusion on 10-km race time.  JAMA. 1987;  257 2761-2765
• 2 Chang T M. Hemoglobin-based red blood cell substitutes.  Artif Organs. 2004;  28 789-794
• 3 Crago M S, West S D, McKenzie J E. Effects of diaspirin crosslinked hemoglobin infusion in treadmill-exercised swine.  Heart Vessels. 1999;  14 1-8
• 4 Everitt B, Raber-Hesketh (ed) S. Analyzing Medical Data Using S-PLUS. New York; Springer-Verlag 2001
• 5 Gonzalez-Alonso J, Olsen D, Saltin B. Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery.  Circ Res. 2002;  91 1046-1055
• 6 Hughes G, Yancey E, Albrecht R, Locker P, Francom S, Orringer E, Antal E, Jacobs E. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.  Clin Pharmacol Ther. 1995;  58 434-443
• 7 Jones M, Pedoe D. Blood doping - a literature review.  Br J Sports Med. 1989;  23 84-88
• 8 Kasper S M, Grune F, Walter M, Amr N, Erasmi H, Buzello W, Bischoff A. The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery.  Anesth Analg. 1998;  87 284-291
• 9 Kasper S M, Walter M, Grune F, Bischoff A, Erasmi H, Buzello W. Effects of a hemoglobin-based oxygen carrier (HBOC‐201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery.  Anesth Analg. 1996;  83 921-927
• 10 Kim H W, Greenburg A G. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.  Artif Organs. 2004;  28 813-828
• 11 Lasne F, Crepin N, Ashenden M, Audran M, de Ceaurriz J. Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: screening by electrophoresis.  Clin Chem. 2004;  50 410-415
• 12 Mortensen S P, Dawson E A, Yoshiga C C, Dalsgaard M K, Damsgaard R, Secher N H, Gonzalez-Alonso J. Limitations to systemic and locomotor limb muscle oxygen delivery and uptake during maximal exercise in humans.  J Physiol. 2005;  566 273-285
• 13 Nose Y. Is there a role for blood substitutes in civilian medicine: a drug for emergency shock cases?.  Artif Organs. 2004;  28 807-812
• 14 Schumacher Y O, Ashenden M J. Doping with artificial oxygen carriers - an update.  Sports Med. 2004;  34 141-150
• 15 Varlet-Marie E, Ashenden M, Lasne F, Sicart M T, Marion B, de Ceaurriz J, Audran M. Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: confirmation by size-exclusion HPLC.  Clin Chem. 2004;  50 723-731
• 16 Winslow R M. MP4, a new nonvasoactive polyethylene glycol-hemoglobin conjugate.  Artif Organs. 2004;  28 800-806